Volume 14 - Issue 11 - November 2006
Column
Spotlight
09/04/2008
Dr. Sontheimer is presently Professor and Vice-Chairman, Department of Dermatology and Richard and Adeline Fleischaker Chair in Dermatology Research at the University of Oklahoma Health Sciences Center.
His prior clinical training in...
Dr. Sontheimer is presently Professor and Vice-Chairman, Department of Dermatology and Richard and Adeline Fleischaker Chair in Dermatology Research at the University of Oklahoma Health Sciences Center.
His prior clinical training in...
Dr. Sontheimer is presently...
09/04/2008
The Dermatologist
Chief Medical Editor Message
09/04/2008
People hold many beliefs simply because they were taught to believe them. Other beliefs are supported by experience, and sometimes by a lot of experience. But many of these beliefs can be plain wrong. I’ve been wrong in my professional...
People hold many beliefs simply because they were taught to believe them. Other beliefs are supported by experience, and sometimes by a lot of experience. But many of these beliefs can be plain wrong. I’ve been wrong in my professional...
People hold many beliefs simply...
09/04/2008
The Dermatologist
Chief Medical Editor Message
09/04/2008
As a medical dermatologist, you might already be feeling the impact of consumer-directed healthcare plans. These plans are growing in popularity, and critics are concerned that patients insured under these plans will seek health care less...
As a medical dermatologist, you might already be feeling the impact of consumer-directed healthcare plans. These plans are growing in popularity, and critics are concerned that patients insured under these plans will seek health care less...
As a medical dermatologist, you...
09/04/2008
The Dermatologist
09/04/2008
In growing numbers, payers and employers are taking a position that the most effective way to get a grip on runaway healthcare costs is to involve patients directly in the financial management of their care — in deciding exactly how, when and...
In growing numbers, payers and employers are taking a position that the most effective way to get a grip on runaway healthcare costs is to involve patients directly in the financial management of their care — in deciding exactly how, when and...
In growing numbers, payers and...
09/04/2008
The Dermatologist
09/04/2008
According to findings in the American Medical Group Association’s 2006 Medical Group Compensation & Financial Survey, most medical specialties saw only modest increases in compensation during 2005. However, the survey found that during...
According to findings in the American Medical Group Association’s 2006 Medical Group Compensation & Financial Survey, most medical specialties saw only modest increases in compensation during 2005. However, the survey found that during...
According to findings in the...
09/04/2008
The Dermatologist
09/04/2008
On August 29, 2006, the FDA proposed restrictions on products containing the bleaching agent hydroquinone due to reported concerns about possible carcinogenicity and a link to ochronosis. If implemented, the action would impose an outright...
On August 29, 2006, the FDA proposed restrictions on products containing the bleaching agent hydroquinone due to reported concerns about possible carcinogenicity and a link to ochronosis. If implemented, the action would impose an outright...
On August 29, 2006, the FDA...
09/04/2008
The Dermatologist
09/04/2008
Skin & Aging is proud to bring you this latest installment in its CME series. This series consists of regular CME activities that qualify you for two category 1 physician credit hours. As a reader of Skin & Aging, this course is...
Skin & Aging is proud to bring you this latest installment in its CME series. This series consists of regular CME activities that qualify you for two category 1 physician credit hours. As a reader of Skin & Aging, this course is...
Skin & Aging is proud to...
09/04/2008
The Dermatologist
09/04/2008
FDA Approvals & News
First-of-Its-Kind Acne Treatment
The U.S. Food and Drug Administration (FDA) has approved the first combination product of its kind for treating acne. Ziana Gel, which is a combination of clindamycin phosphate...
FDA Approvals & News
First-of-Its-Kind Acne Treatment
The U.S. Food and Drug Administration (FDA) has approved the first combination product of its kind for treating acne. Ziana Gel, which is a combination of clindamycin phosphate...
FDA Approvals &...
09/04/2008
The Dermatologist
Feature
Pharmacotherapy Update
09/04/2008
Topical imiquimod 5% cream (Aldara) has been efficacious for treating actinic keratosis (AK) using a variety of treatment regimens, including cycle therapy. Cycle therapy is defined as imiquimod 5% cream three times per week for 4 weeks on,...
Topical imiquimod 5% cream (Aldara) has been efficacious for treating actinic keratosis (AK) using a variety of treatment regimens, including cycle therapy. Cycle therapy is defined as imiquimod 5% cream three times per week for 4 weeks on,...
Topical imiquimod 5% cream...
09/04/2008
The Dermatologist
Department
Derm Dx
09/04/2008
A 32-year-old Caucasian woman presented to our ambulatory dermatology clinic with recent onset of a pruritic eruption involving her thighs, legs, arms and abdomen.
A 32-year-old Caucasian woman presented to our ambulatory dermatology clinic with recent onset of a pruritic eruption involving her thighs, legs, arms and abdomen.
A 32-year-old Caucasian woman...
09/04/2008
The Dermatologist
